T-cell lymphoma complicated by myelofibrosis : report of three cases and review of literature
T-cell lymphoma complicated by myelofibrosis : report of three cases and review of literature
复制标题
T细胞淋巴瘤并发骨髓纤维化三例报告并文献复习
DOI:
--
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
M. Noguchi
中科院分区:
文献类型:
--
作者:
Y. Sekiguchi;Syuichi Shirane;H. Takizawa;M. Wakabayashi;K. Sugimoto;S. Tomita;H. Izumi;N. Nakamura;T. Sawada;Y. Ohta;N. Komatsu;M. Noguchi
Primary myelofibrosis (MF) is a rare cancerous condition that disrupts normal blood cell production and causes scar tissue to accumulate within the bone marrow. MF complicating malignant lymphoma is rare and its cause often remains unknown, but, like primary MF, its pathogenesis is likely related to cytokines produced by proliferating megakaryocytes, monocytes, and histiocytes. We have experienced three cases of peripheral T-cell lymphoma (PTCL) complicated by MF. In each case, no evidence of central nervous system infiltration was found on admission; however, bone marrow infiltration was present. We carried out a chronological analysis of the cytokine production by malignant cells in these three patients by means of lymph node and bone marrow immunostaining. Malignant cells from lymph nodes and bone marrow sampled before treatment stained positive for cytokines: platelet-derived growth factor (PDGF) and tumor necrosis factor-α (TNF-α) in case 1; PDGF in case 2; and PDGF, TNF-α, and transforming growth factor-β in case 3. These cytokines were considered to have been the cause of MF in each case. A literature search indicated that 16 cases of T-cell lymphoma complicated by MF (including our three cases) have been reported to date. Data on cytokine production by malignant cells given in these reports are summarized. Much remains to be clarified concerning the role of cytokines in the development of MF. Consequently, we plan to carry out chronological examinations of cytokines in the serum and immunostaining for cytokines in cases of PTCL and malignant lymphoma, both those complicated and not complicated by MF.
DOI:
--
发表时间:
2005
期刊:
Leuk Lymphoma. 46 4
影响因子:
--
作者:
Ito K;Nakazato T;et al.;Takedatsu.H;Hashiguchi M;Takedatsu. H;Mori. T;Takedatsu. H;Ohtsubo K;Okabe s et al.;Tauchi t et al.;Okabe s et al.
通讯作者:
Okabe s et al.